A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202)
一项针对接受铂类化疗后病情进展的肛管鳞状细胞癌患者的 retifanlimab (INCMGA00012) II 期研究 (POD1UM-202)
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2022.100529
Rao, S; Anandappa, G; Capdevila, J; Dahan, L; Evesque, L; Kim, S; Saunders, M P; Gilbert, D C; Jensen, L H; Samalin, E; Spindler, K-L; Tamberi, S; Demols, A; Guren, M G; Arnold, D; Fakih, M; Kayyal, T; Cornfeld, M; Tian, C; Catlett, M; Smith, M; Spano, J-P